USP39 promotes malignant proliferation and angiogenesis of renal cell carcinoma by inhibiting VEGF-A165b alternative splicing via regulating SRSF1 and SRPK1. This evidence concerns the gene SRPK1 and hereditary clear cell renal cell carcinoma.